Information Provided By:
Fly News Breaks for February 6, 2017
TKPYY, PRAH
Feb 6, 2017 | 07:48 EDT
As previously reported, Credit Suisse analyst Erin Wilson Wright upgraded PRA Health (PRAH) to Outperform from Neutral on greater enthusiasm for the company's recent partnership with Takeda (TKPYY), an incrementally more positive outlook for the broader functional outsourcing market, and relatively healthy CRO industry fundamentals. The analyst also raised her price target on PRA Health's shares to $67 from $50.
News For PRAH;TKPYY From the Last 2 Days
There are no results for your query PRAH;TKPYY
I agree to the thefly.com's disclaimer & terms of use
About Privacy Terms of Use

© 1996-2018 TheStreet, Inc., 14 Wall Street, 15th Fl, NY, NY 10005

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.